From Date :
To Date :
Serivce :
Query :
Keywords :
 ( Seprate With , )
Seven deaths in UK among AstraZeneca vaccine recipients after blood clots
The UK medical regulator said Saturday that out of 30 people who suffered blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.
Political role under fire in European AstraZeneca vaccine suspensions
The decision by more than a dozen European countries to suspend AstraZeneca’s COVID-19 shot faced deepening scrutiny on Wednesday, amid concerns the step could undermine public confidence and delay efforts to beat the coronavirus pandemic.
Italy under virus curbs again as Dutch, Irish stop AstraZeneca shots
Coronavirus restrictions were reimposed across much of Italy on Monday, while Ireland and the Netherlands became the latest countries to suspend AstraZeneca's COVID-19 shots over blood clot fears despite the firm and the WHO insisting there is no risk.
Oxford/AstraZeneca jab fails to prevent mild and moderate COVID from South African strain, study shows
The Oxford/AstraZeneca COVID-19 vaccine does not appear to offer protection against mild and moderate disease caused by the viral variant first identified in South Africa, according to a new study.
'Pivotal moment' as Britain set to roll out AstraZeneca vaccine
Britain will become the first country to roll out the low cost and easily transportable AstraZeneca and Oxford University COVID-19 vaccine on Monday, another step forward in the global response to the pandemic.
AstraZeneca COVID vaccine has 'winning formula': CEO
The COVID-19 vaccine developed by the British drugs group AstraZeneca and the University of Oxford has achieved a "winning formula" for efficacy, the company's chief executive said.
AstraZeneca says its vaccine should be effective against new coronavirus variant
British drugmaker AstraZeneca Plc. told Reuters its COVID-19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation.
AstraZeneca vaccine trial will clear confusion on how well it works: US scientist
A top US scientist overseeing COVID-19 vaccine trials expects a large US study to determine how effective AstraZeneca's experimental inoculation is, following perplexing results from other trials released by the company and partner Oxford University.
Pfizer to buy antibiotics business from AstraZeneca
Pharmaceutical company AstraZeneca (AZN.L) has agreed to sell its small molecule antibiotics business to Pfizer Inc (PFE.N) in a deal that could be valued at more than $1.5 billion.

Page Generated in 1/8734 sec